U.S. jury finds Theranos founder Elizabeth Holmes guilty of fraud

After a monthslong trial, Elizabeth Holmes has been found guilting of defrauding private investors.

Published : Jan 04, 2022 15:50 IST

Holmes (right) was able to raise millions in investment after lying about the capability of her company's blood tests.

Holmes (right) was able to raise millions in investment after lying about the capability of her company's blood tests.

A U.S. jury found the former CEO of Theranos, Elizabeth Holmes, guilty of conspiracy to defraud investors on January 3. The founder of the blood-testing start-up was convicted on four out of 11 counts. She faces up to 20 years in prison for each count, a total of 80 years maximum, although the sentence will likely be lower. The guilty verdicts revolved around defrauding investors, or conspiring to defraud them. The jury acquitted her on the charges of defrauding patients.

Silicon scandal

Prosecutors had accused the 37-year-old Holmes of convincing investors that Theranos machines could run various blood tests with smaller samples than standard methods. She had risen to fame in Silicon Valley with the launch of her company in 2003. The accusations of fraud date back to the period from 2010 to 2015. She managed to raise millions from private investors, including the media magnate Rupert Murdoch. The former company boss was also charged with misleading patients about how accurate their test results were.

Tricky company practices

It later turned out that the company had been secretly relying on conventional blood test machines manufactured by Siemens, according to prosecutors. The story came to light after the Wall Street Journal published articles questioning the validity of the Theranos tests. Holmes was subsequently indicted in 2018. Holmes's defense attorney tried to frame her client as a hardworking young entrepreneur who was trying to change the world. But the prosecution depicted her instead as an unsuccessful businesswoman who "chose fraud over business failure."

ab/fb (Reuters, AP)

Sign in to Unlock member-only benefits!
  • Bookmark stories to read later.
  • Comment on stories to start conversations.
  • Subscribe to our newsletters.
  • Get notified about discounts and offers to our products.
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide to our community guidelines for posting your comment